QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a multi-layered, slow-release cannabinoid chewing gum. Not for the candy stand, MedChewRx® is seeking FDA and EMA approval for the treatment of pain and spasticity associated with multiple sclerosis. Characteristically, QPS is […]
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients Read More »
